Brigatinib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Brigatinib
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Brigatinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 2 KDMF, 3 NDC API, 5 Listed Suppliers

9 API Suppliers
2 KDMF
3 NDC API
5 Listed Suppliers

DEVELOPMENTS

24 Drugs in Development

24 Drugs in Development

INTERMEDIATES

14 Intermediate Suppliers

14 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers, 3 FDA Orange Book, 5 Europe, 5 Canada, 4 Australia, 5 South Africa

22 FDF Dossiers
3 FDA Orange Book
5 Europe
5 Canada
4 Australia
5 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 180MG, TABLET;ORAL - 30MG, TABLET;ORAL - 90MG

TABLET;ORAL - 180MG
TABLET;ORAL - 30MG
TABLET;ORAL - 90MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 5 Gangwal Chemicals, 2 Ideal Cures, 1 Ingredion Pharma Solutions, 13 Kerry, 2 Keval Exports, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 9 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

1 SPI Pharma
1 DKSH
4 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
5 Corel Pharma Chem
5 DFE Pharma
5 Gangwal Chemicals
2 Ideal Cures
1 Ingredion Pharma Solutions
13 Kerry
2 Keval Exports
9 Microlex e.U
2 Nitika Pharmaceutical Specialities
1 Novo Excipients
2 Pharmatrans-Sanaq
2 Pluviaendo
3 Prachin Chemical
9 Roquette
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
9 Sigachi Industries
3 Silverline Chemicals
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Fillers, Diluents & Binders, 14 Disintegrants & Superdisintegrants, 13 Coating Systems & Additives, 12 Granulation, 12 Direct Compression, 11 Lubricants & Glidants, 10 Thickeners and Stabilizers, 8 Co-Processed Excipients, 7 Controlled & Modified Release, 3 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 2 Taste Masking, 2 API Stability Enhancers, 2 Parenteral, 1 Film Formers & Plasticizers, 1 Topical, 1 Rheology Modifiers

28 Fillers, Diluents & Binders
14 Disintegrants & Superdisintegrants
13 Coating Systems & Additives
12 Granulation
12 Direct Compression
11 Lubricants & Glidants
10 Thickeners and Stabilizers
8 Co-Processed Excipients
7 Controlled & Modified Release
3 Emulsifying Agents
3 Chewable & Orodispersible Aids
2 Taste Masking
2 API Stability Enhancers
2 Parenteral
1 Film Formers & Plasticizers
1 Topical
1 Rheology Modifiers

DIGITAL CONTENT

34 News #PharmaBuzz

34 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 5 Regulatory FDF Prices, 6 Annual Reports

1 US Medicaid Prescriptions
5 Regulatory FDF Prices
6 Annual Reports

MARKET PLACE

2 APIs, 1 FDF Dossiers

2 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents, 3 US Exclusivities, 8 Health Canada Patents

12 US Patents
3 US Exclusivities
8 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 1Borden Ladner Gervais LLP

02 7Gowling WLG (Canada) LLP

filter Patent Reset all filters

8 All

01 42723961

02 42965169

filter Product Reset all filters

8 All

01 8BRIGATINIB

filter Dosage Reset all filters

8 All

01 8TABLET

filter Exp Date Reset all filters

8 All

01 42029-05-21

02 42035-10-21

Product Main Page

01

Gowling WLG (Canada) LLP

Brigatinib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-05-21

Date Granted : 2017-03-21

Brand Name : ALUNBRIG

Patent Number : 2723961

Filing Date : 2009-05-21

Strength per Unit : 30 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-05-21

Date Granted : 2017-03-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG (Canada) LLP

Brigatinib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-05-21

Date Granted : 2017-03-21

Brand Name : ALUNBRIG

Patent Number : 2723961

Filing Date : 2009-05-21

Strength per Unit : 90 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-05-21

Date Granted : 2017-03-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Borden Ladner Gervais LLP

Brigatinib

Peptide Process CMC

Not Confirmed

Borden Ladner Gervais LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-05-21

Date Granted : 2017-03-21

Brand Name : ALUNBRIG

Patent Number : 2723961

Filing Date : 2009-05-21

Strength per Unit : 180 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-05-21

Date Granted : 2017-03-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG (Canada) LLP

Brigatinib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-05-21

Date Granted : 2017-03-21

Brand Name : ALUNBRIG

Patent Number : 2723961

Filing Date : 2009-05-21

Strength per Unit : 90 mg and 180 mg (initiation Pack, Kit)

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-05-21

Date Granted : 2017-03-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Gowling WLG (Canada) LLP

Brigatinib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-10-21

Date Granted : 2021-11-16

Brand Name : ALUNBRIG

Patent Number : 2965169

Filing Date : 2015-10-21

Strength per Unit : 30 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-10-21

Date Granted : 2021-11-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Gowling WLG (Canada) LLP

Brigatinib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-10-21

Date Granted : 2021-11-16

Brand Name : ALUNBRIG

Patent Number : 2965169

Filing Date : 2015-10-21

Strength per Unit : 90 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-10-21

Date Granted : 2021-11-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Gowling WLG (Canada) LLP

Brigatinib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-10-21

Date Granted : 2021-11-16

Brand Name : ALUNBRIG

Patent Number : 2965169

Filing Date : 2015-10-21

Strength per Unit : 180 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-10-21

Date Granted : 2021-11-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Gowling WLG (Canada) LLP

Brigatinib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-10-21

Date Granted : 2021-11-16

Brand Name : ALUNBRIG

Patent Number : 2965169

Filing Date : 2015-10-21

Strength per Unit : 90 mg and 180 mg (initiation Pack, Kit)

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-10-21

Date Granted : 2021-11-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!